Christopher Reimann is currently an Associate Principal Scientist at AstraZeneca, where they support small molecule ligand discovery for novel Antibody-Drug Conjugates. Previously, they served as a Senior Scientist at AstraZeneca from 2020 to 2024, contributing to early oncology R&D and leading synthetic chemistry projects. They completed their Doctor of Philosophy in Organic Chemistry at Caltech in 2020 and held a position as a Graduate Research Assistant there from 2015 to 2020, focusing on synthetic organic chemistry. Additionally, they gained research experience as an Undergraduate Research Assistant at the University of Southern California from 2012 to 2015, where they specialized in bioorganic and medicinal chemistry.
This person is not in the org chart
This person is not in any teams
This person is not in any offices